View full meeting coverage »

Eyetube Meeting Coverage:

OIS RETINA 2018

 

Replay
Cancel

Your 25-second video preview has ended.

to continue watching, please Log In or Register:


Log in / Register

EyePoint Pharmaceuticals

  Channels: Retina | Posted 7/23/2018

Tom Hadley, Vice President, Marketing and Sales, EyePoint Pharmaceuticals, talks about the focus of the new eye care company and gives an update on its new drug application for Yutiq (fluocinolone acetonide intravitreal implant) 0.18 mg 3-year micro-insert for noninfectious posterior segment uveitis.


3 / 11 Series: OIS RETINA 2018